Literature DB >> 10924563

CT criteria for management of blunt liver trauma: correlation with angiographic and surgical findings.

P A Poletti1, S E Mirvis, K Shanmuganathan, K L Killeen, D Coldwell.   

Abstract

PURPOSE: To determine the contrast material-enhanced computed tomographic (CT) criteria for selection of hemodynamically stable patients with blunt hepatic injury for angiographic evaluation.
MATERIALS AND METHODS: Seventy-two patients with blunt liver injury underwent CT and hepatic angiography. Hepatic injuries were graded with CT-based classification. Scans were assessed for evidence of contrast extravasation and laceration or contusion extending into the hepatic vein(s), inferior vena cava, porta hepatis, or gallbladder fossa. Medical, angiographic, and surgical records were reviewed to determine angiographic findings, surgical indications and findings, and outcomes.
RESULTS: Compared with hepatic angiography, CT was 65% (11 of 17 patients) sensitive and 85% (41 of 48 patients) specific for detection of arterial vascular injury. When CT severity grades 2 and 3 were analyzed, the sensitivity and specificity of CT were 100% (three of three patients) and 94% (34 of 36 patients), respectively (P <.001). Injury involving at least one major hepatic vein was found in 15 (88%) of 17 patients who required liver-related surgery and in 23 (42%) of 55 of the other patients (P <.01).
CONCLUSION: CT-based criteria, including hepatic injury grade, signs of arterial vascular injury, and presence or absence of major hepatic venous involvement assists in selecting patients for hepatic angiography and those at increased risk of ongoing or delayed hepatic bleeding or other posttraumatic complications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924563     DOI: 10.1148/radiology.216.2.r00au44418

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  20 in total

1.  Transcatheter arterial embolization in a hemodynamically unstable patient with grade IV blunt liver injury: is nonsurgical management an option?

Authors:  H W Nijhof; F E J A Willemssen; G N Jukema
Journal:  Emerg Radiol       Date:  2005-12-23

2.  Usefulness of multidetector computed tomography for the initial assessment of blunt abdominal trauma patients.

Authors:  Jen-Feng Fang; Yon-Cheong Wong; Being-Chuan Lin; Yu-Pao Hsu; Miin-Fu Chen
Journal:  World J Surg       Date:  2006-02       Impact factor: 3.352

3.  The role of interventional radiology in trauma.

Authors:  Jennifer E Gould; Suresh Vedantham
Journal:  Semin Intervent Radiol       Date:  2006-09       Impact factor: 1.513

Review 4.  Management of blunt liver injury: what is new?

Authors:  J Ward; L Alarcon; A B Peitzman
Journal:  Eur J Trauma Emerg Surg       Date:  2015-04-23       Impact factor: 3.693

5.  Computed Tomography (CT) Imaging of Injuries from Blunt Abdominal Trauma: A Pictorial Essay.

Authors:  Radhiana Hassan; Azian Abd Aziz
Journal:  Malays J Med Sci       Date:  2010-04

6.  Experience with managing liver trauma in southeastern Nigeria.

Authors:  Gu Chianakwana; Ku Umeh; Jo Chianakwana
Journal:  J West Afr Coll Surg       Date:  2011-04

7.  Correlating MDCT Liver Injury Grade and Clinical Outcome in Patients Without Significant Extra-hepatic Injury.

Authors:  Ravi Kumar; Atin Kumar; Vinit Baliyan; Shivanand Gamanagatti; Ashu Seith Bhalla; Raju Sharma; Amit Gupta; Subodh Kumar; M C Misra
Journal:  Indian J Surg       Date:  2015-09-28       Impact factor: 0.656

8.  Management of liver trauma in adults.

Authors:  Nasim Ahmed; Jerome J Vernick
Journal:  J Emerg Trauma Shock       Date:  2011-01

9.  Active extravasation of the abdomen and pelvis in trauma using 64MDCT.

Authors:  Akira M Murakami; Stephan W Anderson; Jorge A Soto; Jennifer L Kertesz; Al Ozonoff; James T Rhea
Journal:  Emerg Radiol       Date:  2009-03-07

Review 10.  Management of liver trauma.

Authors:  S A Badger; R Barclay; P Campbell; D J Mole; T Diamond
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.